Christine R Larson - Net Worth and Insider Trading

Christine R Larson Net Worth

The estimated net worth of Christine R Larson is at least $108,060 dollars as of 2024-04-23. Christine R Larson is the Vice President and CFO of PDL BioPharma Inc and owns about 43,749 shares of PDL BioPharma Inc (PDLI) stock worth over $108,060. Details can be seen in Christine R Larson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christine R Larson has not made any transactions after 2010-05-14 and currently still holds the listed stock(s).

Transaction Summary of Christine R Larson

To

Christine R Larson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christine R Larson owns 2 companies in total, including Dynavax Technologies Corp (DVAX) , and PDL BioPharma Inc (PDLI) .

Click here to see the complete history of Christine R Larson’s form 4 insider trades.

Insider Ownership Summary of Christine R Larson

Ticker Comapny Transaction Date Type of Owner
DVAX Dynavax Technologies Corp 2012-08-13 VP and Chief Financial Officer
PDLI PDL BioPharma Inc 2011-05-23 Vice President and CFO

Christine R Larson Latest Holdings Summary

Christine R Larson currently owns a total of 1 stock. Christine R Larson owns 43,749 shares of PDL BioPharma Inc (PDLI) as of May 14, 2010, with a value of $108,060.

Latest Holdings of Christine R Larson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PDLI PDL BioPharma Inc 2010-05-14 43,749 2.47 108,060

Holding Weightings of Christine R Larson


Christine R Larson Form 4 Trading Tracker

According to the SEC Form 4 filings, Christine R Larson has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the acquisition of 5,000 shares on May 14, 2010, which cost Christine R Larson around $28,550.

Insider Trading History of Christine R Larson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christine R Larson Trading Performance

GuruFocus tracks the stock performance after each of Christine R Larson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christine R Larson is -1.51%. GuruFocus also compares Christine R Larson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christine R Larson within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christine R Larson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christine R Larson

Average Return

10.46%

Average return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.09 -1.51 -7.86 10.46 5.09 11.26
Relative Return to S&P 500(%) -0.96 4.57 -10.51 -5.89 -3.44 -0.57

Christine R Larson Ownership Network

Ownership Network List of Christine R Larson

No Data

Ownership Network Relation of Christine R Larson


Christine R Larson Owned Company Details

What does Dynavax Technologies Corp do?

Who are the key executives at Dynavax Technologies Corp?

Christine R Larson is the VP and Chief Financial Officer of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .

Dynavax Technologies Corp (DVAX) Insider Trades Summary

Over the past 18 months, Christine R Larson made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 238,719 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 4,500,000 shares made by Hack Andrew A. F. .

In summary, during the past 3 months, insiders sold 20,526 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 20,526 shares. During the past 18 months, 4,836,004 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,836,004 shares.

Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dynavax Technologies Corp Insider Transactions

No Available Data

Christine R Larson Mailing Address

Above is the net worth, insider trading, and ownership report for Christine R Larson. You might contact Christine R Larson via mailing address: C/o Pdl Biopharma, 932 Southwood Boulevard, Incline Village Nv 89451.

Discussions on Christine R Larson

No discussions yet.